Author: Chi Heem Wong; Kien Wei Siah; Andrew W Lo
Title: Estimating Probabilities of Success of Clinical Trials for Vaccines and Other Anti-Infective Therapeutics Document date: 2020_4_14
ID: fnrm6a79_5
Snippet: We call the estimated probability of a drug development program transitioning from phase i to phase i+1 the "phase i PoS", and the "estimated overall PoS" is defined as the estimated probability of a drug development program going from phase 1 to regulatory approval in at least one country. The estimated probability of a drug development program transitioning from phase 1 to approval-estimated directly using the method described above-is called t.....
Document: We call the estimated probability of a drug development program transitioning from phase i to phase i+1 the "phase i PoS", and the "estimated overall PoS" is defined as the estimated probability of a drug development program going from phase 1 to regulatory approval in at least one country. The estimated probability of a drug development program transitioning from phase 1 to approval-estimated directly using the method described above-is called the "path-by-path" estimate of the overall PoS, and is reported for all PoS calculations.
Search related documents:
Co phrase search for related documents- describe method and estimate probability: 1
- drug development and overall pos: 1, 2, 3, 4, 5
- drug development and path path: 1, 2
- drug development and regulatory approval: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- drug development program and overall pos: 1
- drug development program and regulatory approval: 1
- estimate probability and path path: 1
- overall pos and regulatory approval: 1
Co phrase search for related documents, hyperlinks ordered by date